Results per Page:
New assay better predicts treatment for two cancers
Fred Hutch researchers develop HRDefine, a new clinical test to better serve patients with tubo-ovarian and triple-negative breast cancer
Dr. Lynn Symonds receives ASCO Career Development Award
‘Homegrown’ Fred Hutch clinician-scholar honored for research on triple-negative breast cancer